Decisive Dividend Corporation (FRA:PC9)

Blueprint Medicines Revenue

Decisive Dividend had revenue of 39.19M CAD in the quarter ending March 31, 2025, with 33.51% growth. This brings the company's revenue in the last twelve months to 137.69M, up 3.23% year-over-year. In the year 2024, Decisive Dividend had annual revenue of 127.85M, down -5.21%.

• Revenue (ttm): 137.69M CAD
• Revenue Growth: +3.23%
• P/S Ratio: 1.05
• Revenue / Employee: 252.64K CAD
• Employees: 545
• Market Cap: 92.62M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	127.85M	-7.03M	-5.21%
Dec 31, 2023	134.88M	36.29M	36.81%
Dec 31, 2022	98.59M	36.10M	57.76%
Dec 31, 2021	62.49M	14.03M	28.96%
Dec 31, 2020	48.46M	1.07M	2.25%